Mittal Shah

Mittal Shah is an experienced professional in the field of biomedical sciences with a focus on immuno-oncology. Currently serving as Associate Director of Translational Biology and Principal Translational Scientist at NovalGen since July 2021, Mittal Shah has contributed to drug discovery and development. Prior roles include Senior Scientist at UCB, where the focus was on tissue remodeling in immunology, and a series of postdoctoral positions at UCL and Imperial College London, emphasizing orthopaedic research. Additionally, Mittal Shah has experience as a consulting project manager at Oxbridge Biotech Roundtable and has held various roles in clinical diagnostics and research assistance. Educational qualifications include a PhD in Biochemistry and Pharmacology from the Royal Veterinary College, an MSc in Molecular Life Sciences from King's College London, and a Bachelor's degree in Biomedical Sciences from Cardiff Metropolitan University.